Reference intervals for bone turnover markers (BTM) and relationships between BTM and fracture risk in older men are not well characterised.
Introduction
The risk of minimal trauma fracture is as important in ageing men as it is for women. Men older than 50 years lose bone at 0.5 -1.0 % per year (1) , contributing to an increase in the 10 year risk of hip or femur fracture from 0.2% to 2.9% between 50 and 80 years of age (2) . About one third of hip fractures occur in men (1) , and mortality following hip fracture is significantly higher in men than in women (3) .
Serum concentrations of bone turnover markers (BTMs) are widely used to monitor responses to antiosteoporosis treatment in clinical trials and in routine clinical practice. In addition, some studies have found BTM measurements contribute independently to fracture risk prediction (4, 5) . The
International Osteoporosis Federation and International Federation of Clinical Chemistry Working
Group nominated serum collagen type I C-terminal cross-linked telopeptide (CTX-I) and serum Nterminal propeptide of type I collagen (PINP) as reference bone turnover markers for use in all studies (4) . Reference intervals for these bone turnover markers in pre-menopausal women have been extensively characterised for use as treatment targets in older women (6) (7) (8) (9) . However, until recently, little high quality reference data was available for men, particularly those in older age groups (10, 11) .
Thus the ability of these BTMs to identify those with abnormally high bone turnover is limited in these patient groups.
Another bone turnover marker, serum osteocalcin (OC), has also received increased interest in recent years and may have utility in fracture prediction. In particular some authors have found higher concentrations of the undercarboxylated form of osteocalcin (ucOC) to be associated with fracture risk, particularly for hip fracture (12) (13) (14) . Only one previous study has examined this in elderly men (14) . Whether this result can be generalised to elderly men in other populations has not been investigated.
We measured the BTMs total OC (tOC), ucOC, PINP and CTX-I in a large well-characterised cohort of community-dwelling older Australian men. We aimed to (i) define reference intervals for BTMs in a subset of older men in optimal health, (ii) identify the factors associated with the BTMs across the whole cohort and (iii) explore whether BTMs in this age group were associated with incident fracture during follow-up.
Methods

Study population
The Health In Men Study (HIMS) is a population-based cohort study of community-dwelling older men in Perth, Western Australia. A total of 12,203 men of predominantly Caucasian origin completed a questionnaire and attended a screening medical examination in Wave 1 (W1; 1996 Defining optimal health in older men
We studied a sample of men of the W2 cohort who were considered to be in optimal health. Firstly, global perception of health was assessed at W2 with the question, "In general, would you say your health is …?" The five responses available were 'excellent', 'very good', 'good', 'fair', and 'poor'.
This measure has been validated as a predictor of mortality in older men (18) . The subset of older men reporting 'excellent' or 'very good' health without a history of smoking, diabetes, cardiovascular disease, cancer, depression, or dementia were considered to be in optimal health for defining reference intervals. Healthy men with non-fasting samples were excluded from analysis of reference intervals.
Laboratory assays
Blood samples were collected between 0800 and 1030 h at W2. Serum was prepared immediately after phlebotomy and stored at -80 C until assayed. ucOC was estimated following incubation of serum samples with hydroxyapatite (5 mg/mL) (Calbiochem, catalogue number 391947) for 1 hour with continuous mixing as described by
Gundberg et al. (20) . The OC in the supernatant was estimated using the same assay as for tOC and was reported as a concentration and as a fraction of the total. For an OC reference sample with expected fractional hydroxyapatite binding of 0.80, kindly supplied by Professor Caren Gundberg (Yale School of Medicine, New Haven, CT, USA), mean fractional hydroxyapatite-bound OC was 0.77 and between-run imprecision (CV) was 6.0%. As OC has 3 potential carboxylation sites, and binding to hydroxyapatite is only relatively specific for carboxylated OC (20) , the proportion of unbound OC is a surrogate for the overall ucOC status.
Statistical analysis
All statistical procedures were performed using R (21). Statistical methodologies from published guidelines were applied to define BTM reference intervals between the 2.5th to 97.5th centiles (22) .
Outlying values were removed using Dixon's Outlier Statistic or the one-third rule. To explore the effect of age within the group of optimally healthy men, we performed quantile regression (R package: quantreg: Roger Koenker. http://cran.r-project.org/package=quantreg). Visual inspection of quantile regression plots was performed to determine whether any practical advantage would be gained by stratifying by age within this age-defined group of older men.
Data are presented as median and inter-quartile range. Between-group comparisons were by nonparametric methods. Multivariate analyses were performed using backward stepwise logistic regression. Candidate variables were included based on a P<0.10 on bivariate analysis. The most parsimonious model was chosen using the minimum Aikake's Information Criterion after the removal of each variable. For inclusion in the multivariate analyses, non-normally distributed data were logtransformed to approximate a normal distribution. These data were then normalised to a distribution where the mean value was zero and the standard deviation was 1.
Results
Demographic and clinical characteristics of the entire cohort and the reference sample of older men in optimal health are shown in Table 1 . Two hundred and ninety-eight men were included in the reference sample. None had a past history of osteoporosis, previous hip fracture or Paget's disease and none were taking bisphosphonates or warfarin. Three (1.0%) were taking, or had a history of, oral glucocorticoid use.
The distributions for each BTM in the reference sample are shown in Figure 1 . With the exception of ucOC/tOC, which was normally distributed, each BTM was skewed to the right.
Within the reference group, age was positively associated with tOC, ucOC and CTX-I and negatively associated with ucOC/tOC (r s (P): 0.18 (0.002), 0.12 (0.045), 0.14 (0.018) and -0.15 (0.008), respectively). No BTM was associated with 25-OHD concentration, eGFR or BMI in univariate analyses (data not shown). Therefore further partitioning according to these factors was not required.
Reference intervals for each of the BTM are shown in Table 2 . As age was significantly associated with each BTM, the 2.5 th and 97.5 th quantile regressions were calculated ( Figure 2 ). These indicated that age adjustment of the reference limits would not capture many additional men and was therefore unnecessary. Omitting the 3 men taking glucocorticoids had no impact on the reference intervals (data not shown).
Factors associated with BTMs amongst the whole cohort
The associations of various factors with BTMs across the entire cohort of 4008 men are shown in Table 3 . Men receiving warfarin treatment had higher ucOC and ucOC/tOC, and lower tOC, than men not on warfarin treatment. After adjustment for age and other factors, warfarin remained an independent predictor of ucOC, ucOC/tOC and tOC. There was no significant association of warfarin treatment with either PINP or CTX-I in crude or age-adjusted analyses.
Men taking bisphosphonates had significantly lower BTMs compared to those who were not (Table   3 ). For the bisphosphonate users, after excluding 4 men with Paget's disease, the proportion with tOC, ucOC, PINP and CTX-I below the lower reference limits were 34.3%, 13.4%, 55.2% and 47.8%, respectively. Likewise, the proportions with tOC, ucOC, PINP and CTX-I below the medians of the reference group were 83.6%, 89.6%, 77.6% and 89.6%, respectively.
When BTMs were examined by season, tOC, PINP and CTX-I showed significant associations, with highest values in spring and lowest in winter ( 
Discussion
In this large study of BTMs in older men, we have defined reference intervals for older men in optimal health, and found that tOC predicted incident hip fracture independently of age and other covariates. Of men on bisphosphonate treatment 77-90% had concentrations of CTX-I, PINP and OC below the median of the reference sample. In addition, warfarin treatment was associated with increased ucOC and ucOC/tOC, but not with CTX-I and PINP, as would be expected from its mode of action to inhibit gamma carboxylation.
Our reference interval for CTX-I is similar to those for middle-aged and older men in other studies using the same analytical system (100 -700 ng/L (10) and (69 -760 ng/L) (11). Other assay systems for CTX-I may give significantly higher reference limits (7). For PINP, our reference interval has a higher upper limit than has been reported by other authors in predominantly younger cohorts of men (10, 11) . This is consistent with the data of Jenkins et al. (10) , which suggested that higher PINP concentrations were more frequent in men >80 years. One limitation of our result is the rather wide 90% confidence interval around the upper limit, which is related to the skewed distribution of results.
The 7 men with PINP values above this reference limit had no history of conditions likely to be associated with increased bone turnover and renal function and vitamin D status were normal. Hence these men were retained in the reference sample. Our upper reference limit for CTX-I in men is lower than a recently proposed provisional Australian reference interval for women > 70 years (100-1000 ug/L), but our upper reference limit for PINP is similar to that proposed for men and women >70 years (15-115 ug/L (23) . That publication highlighted the paucity of reference interval data for BTMs in people of this age group (23).
We are not aware of published reference interval data for tOC measured by the Roche assay in predominantly Caucasian subjects. Hu et al. (24) used this assay to determine reference intervals in younger Chinese adults (35-45 years old), obtaining a range for men of 5.58 -28.62 ug/L, somewhat lower than our result. Their ranges for CTX-I and PINP were also lower than ours, with upper limits of 612 ng/L and 65.49 ug/L respectively. As these limits are lower than those found in younger Australian (10) and Spanish (11) men the possibility remains that ethnicity-specific reference intervals may be needed for different populations.
We found significant associations between tOC, ucOC, CTX-I and incident hip fractures in univariate analyses. In multivariate analysis, tOC remained independently associated with incident hip fracture.
Studies of the association between fracture risk and BTMs in women have been inconsistent, especially after adjustment for confounders such as age and bone mineral density (BMD) (4). In men, fewer studies have been carried out but again, their conclusions are inconsistent. In the MrOS study (25) , which included 72 men with and 933 men without hip fracture followed for up to 5 years, serum CTX-I and PINP were associated with fracture independently of age, but not of BMD. However in other studies, these BTMs were not associated with any type of incident fracture after adjustments that included age and BMD (26) (27) (28) . OC was not associated with incident fracture in 3 studies carried out in men (14, 27, 28) . Small sample size and low fracture incidence may have limited the power of several of these studies, but a recent meta-analysis found modest but significant associations between PINP, CTX-I and incident osteoporotic fracture (5). Our observations therefore contrast with these other studies and suggest that OC may be more informative in older men than CTX-I and PINP.
Significant associations between carboxylation isoforms of OC and incident fracture risk have been reported in men and women (12) (13) (14) . However only 2 of these studies included adjustment for age and BMD, so the robustness of these observations is difficult to determine. In our study ucOC, but not ucOC/tOC, was associated with hip fracture in unadjusted analysis, but this association was lost after adjustment.
We found that most men who reported bisphosphonate use had BTMs below the reference group medians. The mean of the pre-menopausal female BTM reference interval has been suggested as a treatment target for effective anti-resorptive therapy; for the methods used in the current study, these were 38.0 ug/L for PINP and 297 ng/L for CTX-I (7), close to the medians for our reference sample of men. Although we cannot verify the compliance of the men in our study, these results suggest that the majority are being treated effectively. Further studies are needed to establish whether the reference group medians would be appropriate treatment targets in older men.
The prevalence of vitamin D deficiency, defined as 25OHD < 50 nmol/L, in our sample of older men was 21.2%. This is lower than reported in a sample of all Australian older men (27.6%) (29) and in older men living in Sydney, Australia (43%) (30) . A number of social and cultural factors may influence 25OHD concentrations and differences in these may have contributed to the differences in observed prevalences. In addition survivor bias may have affected this result. Nevertheless we did not see any association between vitamin D status and BTM concentrations, consistent with other authors (7).
Our data showed significant seasonal variation for tOC, PINP and CTX-I, with peak values in spring and lowest values in winter. This has been observed in several cross-sectional studies, with peak values in spring or summer and nadirs in autumn or winter (12, (31) (32) (33) . In those publications this was ascribed to seasonal variation in sunlight exposure and vitamin D status (12, 32) . We also observed significant seasonal variation in 25OHD concentration, with the nadir 25OHD in winter and spring, ahead of the peak bone turnover in spring. The magnitude of the seasonal differences in BTM is small compared to the 90% confidence intervals of the BTM reference limits and will not impact significantly on the proposed reference intervals.
Men taking warfarin had significantly lower ucOC and ucOC/tOC values, as expected from the mode of action of this drug (34) . We also observed that these men had lower tOC. In one study, warfarin treatment had no effect on tOC concentrations (34). We are not aware of other high quality evidence to support or explain this observation and the possibility remains that it has arisen by chance.
Limitations of our study include the absence of BMD measurements in this cohort of men, hence we cannot ascertain the prevalence of osteopenia and cannot adjust the associations of BTMs with fracture incidence for this factor. The men in this study were almost exclusively Caucasian and therefore the reference intervals may not apply to men of other ethnicities; due to the low prevalence of vitamin D deficiency, they may not apply to men living in areas with higher rates of vitamin D deficiency. We cannot comment on reference intervals in younger men, nor in women. The samples in this study had been stored at -80C for 8 -11 years. However, the design of the OC and PINP assays (35, 36) and innate stability of PINP and CTX-I to freeze-thaw cycles (37, 38) suggest that major deterioration in storage would not be expected. Data on glucocorticoid use were collected from questionnaires completed by the men and did not include dose information; this limits our ability to explain the small effect of oral glucocorticoid use on BTMs. The incidence of hip fracture in the entire cohort of men was low, so our ability to define an association of fracture risk and BTM is 
